These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 2944579

  • 1. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ, Isotalo HE, Kivinen ST, Vihko RK.
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [Abstract] [Full Text] [Related]

  • 2. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
    Neumannova M, Kauppila A, Vihko R.
    Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A, Vierikko P, Kivinen S, Stenbäck F, Vihko R.
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [Abstract] [Full Text] [Related]

  • 4. Cycle variation and distribution in the concentration of cytosol estrogen and progesterone receptors in the normal human uterus and myoma.
    Ochiai K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):945-52. PubMed ID: 7240872
    [Abstract] [Full Text] [Related]

  • 5. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
    Neumannová M, Kauppila A, Kivinen S, Vihko R.
    Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
    [Abstract] [Full Text] [Related]

  • 6. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP, Stehman FB, Michael H, Young PC, Ehrlich CE.
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [Abstract] [Full Text] [Related]

  • 7. Estrogen and progesterone receptor status in breast cancer in Kuwait female population.
    Paszko Z, Omar YT, Nasralla MY, Jazzaf H, Bouzubar N, Temmim L, Padzik H.
    Neoplasma; 1993 Nov; 40(2):127-32. PubMed ID: 8350956
    [Abstract] [Full Text] [Related]

  • 8. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM.
    Cancer Res; 1987 Apr 01; 47(7):1830-5. PubMed ID: 3545455
    [Abstract] [Full Text] [Related]

  • 9. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature.
    Kauppila A.
    Acta Oncol; 1989 Apr 01; 28(4):561-6. PubMed ID: 2675940
    [Abstract] [Full Text] [Related]

  • 10. Female sex steroid receptors in gynecological malignancies: clinical correlates.
    Vihko R, Isotalo H, Kauppila A, Vierikko P.
    J Steroid Biochem; 1983 Jul 01; 19(1C):827-32. PubMed ID: 6887902
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome in endometrial cancer.
    Kauppila A, Grönroos M, Nieminen U.
    Obstet Gynecol; 1982 Oct 01; 60(4):473-80. PubMed ID: 6214734
    [Abstract] [Full Text] [Related]

  • 12. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R, Jänne O, Kauppila A.
    Ann Clin Res; 1980 Oct 01; 12(5):208-15. PubMed ID: 7015983
    [Abstract] [Full Text] [Related]

  • 13. Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment.
    Kauppila A, Vierikko P, Isotalo H, Rönnberg L, Vihko R.
    Acta Obstet Gynecol Scand Suppl; 1984 Oct 01; 123():45-9. PubMed ID: 6093422
    [Abstract] [Full Text] [Related]

  • 14. [Endometrial cancer and steroid hormone receptors].
    Nyholm HC.
    Ugeskr Laeger; 1990 Feb 26; 152(9):593-7. PubMed ID: 2408223
    [Abstract] [Full Text] [Related]

  • 15. [Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma--relation between clinical aspects and histopathology].
    Gao YL.
    Zhonghua Zhong Liu Za Zhi; 1985 Nov 26; 7(6):451-4. PubMed ID: 3836850
    [Abstract] [Full Text] [Related]

  • 16. [Hormonal therapy of endometrial cancer].
    Kato J.
    Gan No Rinsho; 1985 Jul 26; 31(9 Suppl):1182-8. PubMed ID: 4057575
    [Abstract] [Full Text] [Related]

  • 17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M.
    Gynecol Oncol; 1999 Mar 26; 72(3):331-6. PubMed ID: 10053103
    [Abstract] [Full Text] [Related]

  • 18. Sex steroid receptors in endometrial cancer.
    Chambers JT.
    Yale J Biol Med; 1988 Mar 26; 61(4):339-50. PubMed ID: 3055700
    [Abstract] [Full Text] [Related]

  • 19. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B, Alm P, Borg A, Fernö M, Grundsell H, Johnsson JE, Norgren A, Tropé C.
    Anticancer Res; 1982 Mar 26; 2(4):203-7. PubMed ID: 7149649
    [Abstract] [Full Text] [Related]

  • 20. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
    Horvath G, Johnsson JE, Tropé C, Samuelsson L, Alm P, Olsson H.
    Neoplasma; 1990 Mar 26; 37(1):43-6. PubMed ID: 2320180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.